1.The endothelial cell apoptosis rate of 3TSR and 3TSR plus Gem group was significantly higher than control and Gem group(P＜0.05).
3TSR组及3TSR+Gem组血管内皮细胞凋亡率又高于对照组和Gem组(P＜0．05)。
2.Methods:42 cases of elderly patients have been cytologically and pathologically confirmed with locally advanced unresectable NSCLC,the age of the patients ranged from 65 to 75.The patients were treated with the combined regimen of gemcitabine and cisplatin. GEM 1 000 mg/m2 intravenously injected by drip on the 1st,8th day and the dosage of CBP was AUC 5 that was used on the 1st day,21 days apart to each cycle,most patients received 2-3 cycles.
方法:对于有明确的病理或细胞学诊断,年龄在65~75岁的晚期不可手术的NSCLC患者,应用GEM联合CBP化疗,用药方法为:GEM1000 mg/m2静脉滴入第1、8天,CBP AUC为5,在第1天给药。 21 d为1个周期,共2~3个周期。
3.Methods:The patients with NSCLC were randomized to two groups:the observed group was treated with nedaplatin(NDP 100 mg/m2,iv,d1)plus gemcitabine(GEM 1 000mg/m2,iv,d1,d8,every 3 weeks),and the control group was treated with cisplatin(DDP,80～100mg/m2,iv,d1)plus gemcitabine(GEM 1 000mg/m2,iv,d1,d8,every 3 weeks).
方法:将43例NSCLC病人随机分成试验组和对照组,试验组:NDP100mg/m2,静注,第1天; 吉西他滨(GEM)1000mg/m2,静注,第1、8天。
4.The lifetime of electrons, the drift velocity and diffusion are simulated and investigated, with the help of Garfield. With a theoretical analysis, a gas mixture of Argon, CH4 and CF4 is proposed. The performance of GEM with the proposed gas is excellent with regard to the gas gain and energy resolution, which makes it a promising candidate for the future GEM-based TPC.
结合分析论证,得到了以Ar,CH4和CF4为主要成分的气体作为工作气体时TPC的性能指标．并且测试了该气体中的读出GEM探测器的能量分辨率、气体增益等性能参数,获得了很好的结果．
5.Image Examination of Comet Hale-Bopp and α Gem
海尔-波普彗星和α Gem星图象检测结果
6.Clinical benefit response (CBR)was 66.7% in group GEM and 12.5% in group BSC(P
临床受益反应(CBR)GEM组66.7%,BSC组12.5%,有统计学差异(P
7.An Efficient GEM Training Algorithm for Probability Mapping Networks
一种PMN网络的GEM训练算法
8.Methods 62 advanced non-small cell lung cancer patients vithout surgical treatment were radomized into 2 groups with NP(NVB+DDP) and GP(GEM+DDP).
方法选择62例不能手术的晚期非小细胞肺癌病人,随机分为2组,分别采用NP(NVB+DDP)方案及GP(GEM+DDP)方案治疗。
9.We have constructed a new expression vector by introducing T7 phage gene 10 SD sequence and T7terminator sequence into multicloning sites of p~(GEM7Zf)(+). This vector has following characteristics:1.The 8bp opti-mal distance between SD and ATG;
以p~(GEM7Zf(+))为出发质粒,在其多克隆位点两端加入T7 phage gene 10的SD序列和T7 terminator 序列,构建成一个新的表达载体,它具有如下特点:1.SD 保守序列AGGAG 至ATG 之间8bp 的最佳间隔;
10.OBJECTIVE:To observe and compare the rationality among three combined chemotherapy regimens-TC(TAX+CBP),GP(GEM+DDP) and NP (NVB+DDP) from the perspective of pharmacoeconomics.
目的:从药物经济学角度,观察比较TC(TAX+CBP)、GP(GEM+DDP)和NP(NVB+DDP)联合化疗方案的合理性。
